DBV Technologies
DBV is a France-based biopharmaceutical company that develops and commercializes epicutaneous immunotherapy products for patients with food allergies.
Business Model:
Revenue: $7.5M
Employees: 51-200
Industries / Tags:
Detailed DBV Technologies Information
Geographic Data
Address: 177-181 avenue Pierre Brossolette
City: Montrouge
State: île-de-france
Zip: 92120
Country: FR
Financial Info
Stage:
post ipo equity
Raised Last:
$192M
Raised Total:$243M
Social
Metrics
2,152,923Website Global Rank
9,317Website Monthly Traffic
Twitter Followers
Description
DBV is a France-based biopharmaceutical company that develops and commercializes epicutaneous immunotherapy products for patients with food allergies.
Contact Phone:
Contact Email:
DBV Technologies went public on 4/5/2012 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/5/2012
Ticker Symbol:
DBVT
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
